HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogren, S. Articles by Lindahl, U. Search for Related Content PubMed PubMed Citation Articles by Ogren, S. Articles by Lindahl, U. Social Bookmarking                      What's this?

JBC, Vol. 250, Issue 7, 2690-2697, Apr, 1975

Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma

S. Ogren and U. Lindahl

Heparinase was isolated from a transplantable mouse mastocytoma, by salt extraction of a particulate fraction sedimenting at 20,000 times g, followed by precipitation from saturated ammonium sulfate. By use of gel chromatography through Sepharose 4B, the enzyme was shown to degrade macromolecular. 35S-labeled, mastocytomal heparin (K-av about 0.25) to products similar in size to commercial heparin (K-av about 0.85), apparently by nonrandom cleavage of a limited number of glycosidic linkages per molecule. Prolonged incubation times (up to 5 days, with repeated addition of enzyme) did not result in further degradation of the product. No significant depolymerizing activity was observed with any other glycosaminoglycan tested, including chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparan sulfate, and commercial heparin. The pH optimum for degradation of macromolecular heparin was around pH 5. The nature of the linkage cleaved by the heparinase was investigated by reduction of unlabeled polysaccharide degradation products with sodium [3H]borohydride. The degraded chains (but not the macromolecular substrate) incorporated significant amounts of tritium. An essentially monodisperse fraction of the labeled, degraded heparin was subjected to meniscus depletion sedimentation equilibrium ultracentrifugation, indicating a molecular weight of 14,500. By relating the molecular weight to the specific activity of the preparation, the amount of reducible groups was calculated to be approximately one per molecule. The 3H-labeled heparin was degraded to monosaccharides by a combination of acid hydrolysis and cleavage due to deamination with nitrous acid. Analysis of the degradation products, by paper electrophoresis and paper chromatography, showed a major radioactive component which behaved like L-gulonic acid. Since [3H]gulonic acid would be the expected reduction product of a polysaccharide molecule, containing a glucuronic acid residue in terminal position, these results tentatively suggest that the heparinase is an endoglucuronidase. By direct deaminative cleavage (no hydrolysis) of the 3H-labeled heparin, the glucosamine unit in penultimate position (i.e. adjacent to the [3H]gulonic acid residue) was shown to be 52% N-sulfated and 48% N-acetylated. As only 14% of the glucosamine was N-acetylated in the macromolecular heparin substrate, it is suggested that cleavage of this polysaccharide, by the heparinase, occurs in regions more abundant in N-acetylated glucosamine residues than other portions of the molecule. The possibility that formation and degradation of macromolecular heparin occurs also in mammalian species other than rodents in discussed.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Gong, P. Jemth, M. L. E. Galvis, I. Vlodavsky, A. Horner, U. Lindahl, and J.-p. Li Processing of Macromolecular Heparin by Heparanase J. Biol. Chem., September 12, 2003; 278(37): 35152 - 35158. [Abstract] [Full Text] [PDF]

				Y. Okada, S. Yamada, M. Toyoshima, J. Dong, M. Nakajima, and K. Sugahara Structural Recognition by Recombinant Human Heparanase That Plays Critical Roles in Tumor Metastasis. HIERARCHICAL SULFATE GROUPS WITH DIFFERENTIAL EFFECTS AND THE ESSENTIAL TARGET DISULFATED TRISACCHARIDE SEQUENCE J. Biol. Chem., November 1, 2002; 277(45): 42488 - 42495. [Abstract] [Full Text] [PDF]

				K. J. Bame Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans Glycobiology, June 1, 2001; 11(6): 91R - 98R. [Abstract] [Full Text] [PDF]

				D. S. Pikas, J.-p. Li, I. Vlodavsky, and U. Lindahl Substrate Specificity of Heparanases from Human Hepatoma and Platelets J. Biol. Chem., July 24, 1998; 273(30): 18770 - 18777. [Abstract] [Full Text] [PDF]

				S. Yamada, Y. Yamane, H. Tsuda, K. Yoshida, and K. Sugahara A Major Common Trisulfated Hexasaccharide Core Sequence, Hexuronic Acid(2-Sulfate)-Glucosamine(N-Sulfate)-Iduronic Acid-N-Acetylglucosamine-Glucuronic Acid-Glucosamine(N-Sulfate), Isolated from the Low Sulfated Irregular Region of Porcine Intestinal Heparin J. Biol. Chem., January 23, 1998; 273(4): 1863 - 1871. [Abstract] [Full Text] [PDF]

				X. Bai, K. J. Bame, H. Habuchi, K. Kimata, and J. D. Esko Turnover of Heparan Sulfate Depends on 2-O-Sulfation of Uronic Acids J. Biol. Chem., September 12, 1997; 272(37): 23172 - 23179. [Abstract] [Full Text] [PDF]

				M Nakajima, T Irimura, D Di Ferrante, N Di Ferrante, and G. Nicolson Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines Science, May 6, 1983; 220(4597): 611 - 613. [Abstract] [PDF]